NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/02/2024
Back to search
Official data from USPTO
SWARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
04/02/2024
Classification
Registered
Trademark type
Word
Nice classes
5, 44
Filing date
09/20/2022
Registration date
04/02/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2024
Last transaction
04/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
24
Owner location
LONDON, GB
Examiner
CANFIELD III, JOSEPH J
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SWARM ONCOLOGY LIMITED
Delin Ventures Advisors Limited
Representatives
Jonathan A. Menkes KNOBBE, MARTENS, OLSON & BEAR, LLP
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biopharmaceuticals and medicines in the form of cell suspension for IV infusion for cell and gene therapy during cancer treatment; biopharmaceuticals and medicines in the form of cell suspension for IV infusion for the treatment of cancer
Class 44
Medical services; medical treatment services in the nature of providing personalized medicine to patients during the treatment of cancer; medical services in the nature of providing medical treatment through the provision of cell and gene therapy medicines and therapeutics; medical treatment services, namely, medical treatment of cancer by delivering cell and gene therapy medicines via IV infusion
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/16/2024
PUBO
PUBLISHED FOR OPPOSITION
01/16/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/27/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
12/13/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
12/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/01/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
12/01/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/01/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
12/01/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/01/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/29/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/08/2023
GNRT
NON-FINAL ACTION E-MAILED
11/08/2023
CNRT
NON-FINAL ACTION WRITTEN
11/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/13/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/12/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
07/25/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
07/25/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/28/2023
GNRT
NON-FINAL ACTION E-MAILED
04/28/2023
CNRT
NON-FINAL ACTION WRITTEN
04/28/2023
DOCK
ASSIGNED TO EXAMINER
04/18/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
11/09/2022
ALIE
ASSIGNED TO LIE
11/09/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
09/26/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/23/2022
NWAP
NEW APPLICATION ENTERED
09/23/2022
Continuous trademark protection
Get notified about every new filing that threatens SWARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.